Project cooperationUpdated on 23 January 2026
Cooperation to development new drugs and nutraceuticals
CEO at New Approach - Machine Learninf for Pharma&Nutraceuticals
Viseu, Portugal
About
Since we have selected the most promising drugs and nutraceuticals for a specific target, we are seeking a partner to carry out in vitro and in vivo assays to validate our choices. As our approach is based on a mathematical method, the therapeutic target can be in any disease area.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Type
- Partner seeks Consortium/Coordinator
Attached files
Organisation
Similar opportunities
Project cooperation
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Vladan Čokić
Head of Department of molecular oncology at Institute for Medical Research University of Belgrade
Belgrade, Serbia
Project cooperation
Translational Research Platform based on human tissues and primary cells
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Stefano Palea
Chief Executive Officer at Humana Biosciences
31670 - LABEGE, France
Project cooperation
Specificity profiling for therapeutic antibodies and other biologics
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Sven Eyckerman
Associate Professor at Ghent University
Gent, Belgium